ResearcherAzienda ULSS 9 ScaligeraActive in the last 2 years
Jacopo Giuliani
Matched on ORCID iD 0000-0003-4096-2514; OpenAlex author ID A5044009241.
Their work
- Papers
- 8 (first author 7, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 4
2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 8
- Cost-effectiveness of liposomal irinotecan (nal-IRI) combined with 5-fluorouracil and leucovorin in second or subsequent lines for metastatic pancreatic cancer… First author DOI 10.1016/j.pan.2025.08.007↗
- FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer. First author DOI 10.1016/j.pan.2019.01.014↗
- Long-term survival in advanced pancreatic cancer. First author DOI 10.1701/2932.29492↗
- Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice. First author DOI 10.1701/2656.27239↗
- [La combinazione di gemcitabina e oxaliplatino (GEMOX) nel trattamento del carcinoma pancreatico in fase avanzata di malattia: le notizie sulla mia morte sono … First author DOI 10.1701/2829.28584↗
- The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction. First author DOI 10.1016/j.ejso.2015.12.015↗
- Management of advanced pancreatic cancer in daily clinical practice. First author DOI 10.5301/tj.5000428↗
- [Radically resected pancreatic cancer and adjuvant treatment. A review of the literature]. Co-author DOI 10.1701/1241.13711↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Andrea Vincent Bonetti · 6 shared papers, 2016–2019
- Paper FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer. DOI 10.1016/j.pan.2019.01.014↗
- Paper Long-term survival in advanced pancreatic cancer. DOI 10.1701/2932.29492↗
- Paper Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clini… DOI 10.1701/2656.27239↗
- Teodoro Sava · 1 shared paper, 2025
- Fabrizio Drudi · 1 shared paper, 2013
- Alberto Ravaioli · 1 shared paper, 2013
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.